FDA has announced a 2-day public hearing to obtain input on its regulatory oversight of clinical research. The target audience includes industry representatives, investigators, IRBs, professional organizations, advocacy groups, and others involved with clinical trials. Advance registration is required to attend the hearing on April 23 and 24, 2012. Please see the Federal Register notice for more information.
